Richard Maziarz, M.D.
Richard Maziarz, M.D., medical director of the adult blood and marrow stem cell transplant and cellular therapy program in the OHSU Knight Cancer Institute. (OHSU/Kristyna Wentz-Graff)
Richard Maziarz, M.D.
Richard Maziarz, M.D., medical director of the adult blood and marrow stem cell transplant and cellular therapy program in the OHSU Knight Cancer Institute. (OHSU/Kristyna Wentz-Graff)
Richard Maziarz, M.D.
Richard Maziarz, M.D., medical director of the adult blood and marrow stem cell transplant and cellular therapy program in the OHSU Knight Cancer Institute. (OHSU/Kristyna Wentz-Graff)
Cellular therapy program
Richard Maziarz, M.D., medical director of the adult blood and marrow stem cell transplant and cellular therapy program at the OHSU Knight Cancer Institute. Researchers in the program are looking for new ways to treat lethal cancers such as skin cancer. (OHSU/Kristyna Wentz-Graff)
Asian Health & Service Center
Asian Health & Service Center aims to increase culturally and linguistically appropriate cancer resources, educational materials, and support services available to the Asian communities in Oregon. (Photo courtesy of Naim Hasan Photography)
Harney District Hospital Community Assistance
Savanna Cate, (left) program outreach coordinator for the Harney District Hospital Community Assistance for Neighbors with Cancer Program, shares information with patient Debbie Pike. The Burns, Oregon, program received a new grant to conduct a needs assessment of cancer patients in Harney County to identify cancer-related needs and barriers to care. (Photo courtesy Harney District Hospital Community Assistance for Neighbors with Cancer Program)
El Center for Experimental Therapeutics convierte los descubrimientos de laboratorio en tratamientos
Center for Experimental Therapeutics translates lab discoveries to treatments
OHSU researchers identify promising next-generation cancer treatment
Michael Cohen, Ph.D., in his lab with Moriah Arnold, a student in the OHSU Graduate Program in Biomedical Sciences, School of Medicine. (OHSU/Christine Torres Hicks)
Chemistry discovery critical in cancer treatment
Michael Cohen, Ph.D., in his lab with Moriah Arnold, an M.D./Ph.D. student and co-author of the study unveiling a new class of PARP-1 inhibitors. (OHSU/Christine Torres Hicks)